post term pregnancy, post dated pregnancy, prolonged pregnancy,
m.g. reshmi, management of post dated pregnancy,management of post term pregnancy, fetal maturity assesment, post maturity syndrome, mortality and morbidity ,placental dysfunction, aminotic fluid volume in prolonged pregnancy.
Oligohydramnios by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
• Oligohydramnios refers to amniotic fluid volume that is less than expected for gestational age. It is typically diagnosed by ultrasound examination and may be described qualitatively (eg, reduced amniotic fluid volume) or quantitatively (eg, amniotic fluid index ≤5 cm, single deepest pocket <2 cm).
• Oligohydramnios may be idiopathic or have a maternal, fetal, or placental cause The fetal prognosis depends on several factors, including the underlying cause, the severity (reduced versus no amniotic fluid), and the gestational age at which oligohydramnios occurs. Because an adequate volume of amniotic fluid is critical to normal fetal movement and lung development and for cushioning the fetus and umbilical cord from uterine compression, pregnancies complicated by oligohydramnios from any cause are at risk for fetal deformation, pulmonary hypoplasia, and umbilical cord compression.
• Oligohydramnios is associated with an increased risk for fetal or neonatal death, which may be related to the underlying cause of the reduced amniotic fluid volume or due to sequelae of the reduced amniotic fluid volume.
• This topic will discuss issues related to oligohydramnios. Methods of amniotic fluid volume assessment are reviewed separately.
• Oligohydramnios occurs when the amniotic fluid is < 5th centile for gestational age.
• The most common causes are premature rupture of membranes (often missed by the mother) and placental insufficiency, however structural abnormalities such as renal agenesis should be considered.
• Prognosis is linked to gestation at diagnosis and likely development of pulmonary hypoplasia and premature delivery.
• Treatment is by optimising gestation of delivery
Please find the power point on Management of Preterm labor. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
post term pregnancy, post dated pregnancy, prolonged pregnancy,
m.g. reshmi, management of post dated pregnancy,management of post term pregnancy, fetal maturity assesment, post maturity syndrome, mortality and morbidity ,placental dysfunction, aminotic fluid volume in prolonged pregnancy.
Oligohydramnios by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
• Oligohydramnios refers to amniotic fluid volume that is less than expected for gestational age. It is typically diagnosed by ultrasound examination and may be described qualitatively (eg, reduced amniotic fluid volume) or quantitatively (eg, amniotic fluid index ≤5 cm, single deepest pocket <2 cm).
• Oligohydramnios may be idiopathic or have a maternal, fetal, or placental cause The fetal prognosis depends on several factors, including the underlying cause, the severity (reduced versus no amniotic fluid), and the gestational age at which oligohydramnios occurs. Because an adequate volume of amniotic fluid is critical to normal fetal movement and lung development and for cushioning the fetus and umbilical cord from uterine compression, pregnancies complicated by oligohydramnios from any cause are at risk for fetal deformation, pulmonary hypoplasia, and umbilical cord compression.
• Oligohydramnios is associated with an increased risk for fetal or neonatal death, which may be related to the underlying cause of the reduced amniotic fluid volume or due to sequelae of the reduced amniotic fluid volume.
• This topic will discuss issues related to oligohydramnios. Methods of amniotic fluid volume assessment are reviewed separately.
• Oligohydramnios occurs when the amniotic fluid is < 5th centile for gestational age.
• The most common causes are premature rupture of membranes (often missed by the mother) and placental insufficiency, however structural abnormalities such as renal agenesis should be considered.
• Prognosis is linked to gestation at diagnosis and likely development of pulmonary hypoplasia and premature delivery.
• Treatment is by optimising gestation of delivery
Please find the power point on Management of Preterm labor. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Majority of fetal deaths occur in the antepartum period.
There is progressive decline in maternal deaths all over the world. Currently more interest is focused to evaluate the fetal health. The primary objective of antenatal assessment is to avoid fetal death.
Majority of fetal deaths occur in the antepartum period.
There is progressive decline in maternal deaths all over the world. Currently more interest is focused to evaluate the fetal health. The primary objective of antenatal assessment is to avoid fetal death.
Intra uterine Growth Retardation includes Low birth weight (LBW)
Very low birth weight (VLBW)
Extremely low birth weight (ELBW)
Premature
Small for Gestational Age (SGA)
Large for Gestational Age (AGA)
Intrauterine Growth Retardation (IUGR)
Factors affecting Fetal/Baby size:
Conditions associated with symmetric IUGR
IUGR
Intrauterine growth restriction is said to be present in those babies whose birth weight is below the tength percentile of the average for gestational age.
INCIDENCE
Dysmaturity comprised about one third of low birth weight babies.
In developed countries , its overall incidence is about
3-10%
Term babies (5%)
Post term babies (15%)
CAUSES OF IUGR
The causes of IUGR can be grouped as
Maternal causes
Fetal causes
Placental causes
Uterine and Environmental causes.
MATERNAL CAUSES
Pregnancy weight of mother influences the fetal size
Chronic maternal disease condition
Renal disease condition
Malnutrition
Multiple pregnancy
Hypertensive disorders of pregnancy
Severe anemia
Previous baby suffered iugr etc.
FETAL CAUSES
Chromosomal anomalies
Exposure to an infection
German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
Birth defects
(cardiovascular, renal, anencephally, limb defect, etc).
• Placenta or umbilical cord defects.
PLACENTAL FACTORS
Uteroplacental Insufficiency
Fetoplacetal Insufficiency
Abruptio placenta
Placenta previa
Post term pregnancy
UTERINE CAUSES
Septate uterus
Fibroid/ myoma uterus
ENVIRONMENTAL CAUSES
High altitude - lower environmental oxygen saturation
Toxins
PATHOPHYSIOLOGY
Due to maternal and placental causes
Decrease in placental transfer of nutrients and oxygen to the fetus
Resulting in reduced fetal body store of lipids, glycogen
Causes neonatal hypoglycemia
Lack of oxygen
Chronic hypoxia that leads to erythropoietin production
Polycythemia etc
CLASSIFICATION OF IUGR
Based On Pathological Processes
I)Type I- Symmetrical
II)Type II- Asymmetrical
SYMMETRICAL
Symmetric IUGR: (33 % of IUGR Infants)
height, weight, head circumference proportional
early pregnancy insult:
commonly due to congenital infection, genetic disorder, or intrinsic factors
reduced no of cells in fetus
normal ponderal index
low risk of perinatal asphyxia
low risk of hypoglycemia
ASYMMETRICAL
later in pregnancy:
commonly due to utero placental insufficiency, maternal malnutrition, hypoxia, or extrinsic factors
low ponderal index
cell number remains same but size is small
increased risk of asphyxia
increased risk of hypoglycemia
CLINICAL FEATURES OF BABY WITH IUGR AT BIRTH
Weight deficit
Large head circumference
Old man look
Cartilaginous ridges on pinna
Dry wrinkled skin
Length remain unaffected
Open eyes
Well defined creases
Alert and active
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
Signs of recent wasting - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference • Signs of long term growth failure - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
Intrauterine growth restriction when to deliver by dr alka mukherjee & dr apu...alka mukherjee
Molecular basis of IUGR. –
1. Atypical expression of enzymes governed by TGFβ causes the placental apoptosis and altered expression of TGFβ due to hyper alimentation causes impairment of lung function.
2. Crosstalk of cAMP with protein kinases plays a prominent role in the regulation of cortisol levels.
3. Increasing levels of NOD1 proteins leads to development of IUGR by increasing the levels of inflammatory mediators.
4. Increase in leptin synthesis in placental trophoblast cells is associated with IUGR.
A positive history for risk factors of IUGR can raise the problem of an increased surveillance with the specific goal of an early detection of growth insufficiency [23]. Further diagnostic tests could have a better relevance in a selected high-risk population
Serum markers linked to IUGR
The placentation process starts with the migration of trophoblastic cells that invade the walls of spiral arteries and transform them from small caliber high resistant vessels into wide caliber low resistant vessels that deliver blood at low pressure to the intervillous space. Then, the utero-placental circulation develops in two stages: the first stage (until the 10th week of gestation) consists in endovascular plugging of the spiral arteries by trophoblastic cells, subsequently followed by invasion and destruction of the intradecidual spiral arteries; the second stage (between 14-16 weeks of gestation) consists in the invasion of the inner miometrial part of the spiral arteries [27]. The impaired spiral artery transformation is leading to weak development of the utero-placental circulation and is implied in the pathology of preeclampsia and IUGR
Pregnancy associated plasma protein A (PAPP-A), an Insulin–like Growth Factor Binding Protein Protease whose levels depend on placental volume and function, was assessed in several studies with congruent results. In 2000, Ong et al. evaluated 5584 singleton pregnancies at 10-14 weeks of gestation and measured maternal serum free beta human chorionic gonadotropin (β-hCG) and PAPP-A, concluding that low levels of maternal serum PAPP-A or β-hCG were associated with subsequent development of pregnancy
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Iugr chandni
1. IUGR Intra Uterine Growth
Retardation
Chandni Thampi
Assistant Professor
Travancore College Of Nursing
2. Definition :
• Intra uterine growth restriction is said to be
present in those babies whose birth weight is
below the tenth percentile of the average for
the gestational age.
• Growth restriction can occur in preterm, term
or post-term babies.
3. Nomenclature :
• SGA and IUGR are too often used synonymously
although there is a degree of overlap.
• SGA fetus is not necessarily growth retarded.
• The baby may be constitutionally small.
4. Normal fetal growth
• Is characterized by
hyperplasia followed
cellular
by
hyperplasia and hypertrophy and
lastly by hypertrophy alone.
5. Types: Based on the clinical evaluation and ultrasound
examination the small fetuses are divided into:
1. Fetuses that are small and healthy. The birth weight is
less than 10th percentile for their gestational age. They
have normal ponderal index, normal subcutaneous fat
and usually have uneventful neonatal course.
2. Fetuses where growth is restricted by pathological
process (true IUGR). Depending upon the relative size
of their head, abdomen and femur, the fetuses are
subdivided into:
(a) Symmetrical or Type I
(b) Asymmetrical or Type II.
6. Symmetrical (20%) –
• The fetus is affected from the noxious effect
very early in the phase of cellular hyperplasia.
• The total cell number is less. This form of
structural or chromosomal abnormalities
growth retardation is most often caused by
or
congenital infection (TORCH).
• The pathologic process is intrinsic to the fetus
and involves all the organs including the head.
7. Asymmetrical (80%) –
• The fetus is affected in later months during the
phase of cellular hypertrophy.
• The total cell number remains the same but size
is smaller than normal.
• The pathologic processes that too often result in
asymmetric growth retardation are maternal
diseases extrinsic to the fetus.
• These diseases alter the fetal size by reducing
utero-placental blood flow or by restricting the
oxygen and nutrient transfer or by reducing the
placental size.
10. Etiology: The causes of fetal growth retardation can be
divided into four types.
Maternal –
• Maternal nutrition before and during pregnancy –
Critical substrate requirement for the fetus such as
glucose, aminoacids and oxygen are lacking during
pregnancy.
• Maternal diseases- anaemia, hypertension,
antiphospholipid syndrome in the second half of
pregnancy play significant role in the reduction
of the birth weight.
• Toxins- alcohol, smoking ,cocaine,heroine drugs
11. Fetal –
There is enough substrate in the maternal blood and
also crosses the placenta but is not utilized by the
fetus. The failure of non utilization may be due to
(1)Congenital anomalies either cardio vascular, renal or
others
(2)Chromosomal abnormality trisomy 21, trisomy 18
(Edward’s Syndrome), trisomy 16, trisomy 13 and
Turner’s syndrome
(3)Accelerated fetal metabolism due to TORCH agents
(toxoplasmosis, rubella, cytomegalovirus and herpes
simplex) and parvo virus B19
(4)Multiple pregnancy – There is mechanical hindrance
to growth and excessive fetal demand.
12. Placental –
• The causes include cases of poor uterine blood flow to
the placental site for a long time.
• This leads to chronic placental insufficiency with
inadequate substrate transfer.
• This occurs in conditions such as preeclampsia,
essential hypertension, chronic nephritis, organic heart
disease, placental and cord abnormalities such as
chronic placental abruption, infarction, small placenta,
circumvallate placenta, vellamentous insertion of cord
etc.
Unknown
14. • Maternal weight gain remains stationary or at
times falling (less than 2 kg/month during
second half of pregnancy).
• If there is reduction of symphysis fundal height
by 2 cm before 36 weeks or 3 cm thereafter or
the measurement falls below the 10th
percentile.
15. • Measurement of the abdominal girth showing
stationary or falling values.
• Clinical examination by abdominal palpation
to measure the relative growth of the uterus
and its contents is the commonly used method.
The diminishing amniotic fluid volume can
also be assessed with fair degree of accuracy.
16. Fetal ultrasound: BPD and AC measured.
- BPD (biparietal diam) 43-100% accurate
but inaccuracy due to head-sparing in
asymmetric IUGR.
- AC (Abdominal circumference better
sensitivity than that of cephalometry for
IUGR detection.
- HC/AC (Head circumference/abdominal
circumference ratio) is an important
measurement for detection of asymmetric
IUGR infants.
17. - Ratio of femoral length to abdominal
circumference (FL/AC) provides also an
accurate prediction of IUGR.
18. Amniotic fluid volume: oligohydramnios
due to decreased renal blood flow and
urine output.
Blood flow measurements: by Doppler
flow studies, fetal and uterine blood flow
can be measured and therefore
uteroplacental circulation dysfunctions
can be assessed.
20. Physical features at birth
• Weight deficit at birth is about 600 gm
below the minimum in percentile
standard.
• Length is unaffected.
• Head circumference is relatively larger
than the body.
21. Physical features at birth
• Physical features show dry and wrinkled skin
because of less subcutaneous fat,
abdomen, thin meconium stained
scaphoid
vernix
caseosa and thin umbilical cord. All these give
the baby an ‘old man look’. Pinna of ear has
cartilaginous ridges. Plantar creases are well
defined.
• The baby is alert and having normal cry. Eyes
are open.
• Reflexes are normal including Moro-reflex.
23. Complications
Fetal:
(A) Antenatal – Chronic fetal distress, fetal death,
(B) Intranatal – Hypoxia and acidosis
(C) After birth:
Immediate:
(6) Asphyxia (intrauterine and neonatal),
(7) Hypoglycemia due to shortage of glycogen reserve in the
liver as a result of chronic hypoxia
(8) Meconium aspiration pneumonia
(9) Microcoagulation leading to DIC during first day of life.
(10)Hypothermia
(11)Pulmonary hemorrhage
(12)Polycythaemia
(13)Hyperviscosity syndrome
(14)Necrotizing enterocolitis due to reduced intestinal blood flow.
24. Late:
• Symmetrical growth retarded baby is likely to
grow slowly after birth.
• Whereas the asymmetrical one is more likely to
grow faster after birth.
• The fetuses have retardation of growth
evidenced before third trimester are likely to
have retarded neurologic and intellectual
development in infancy.
• The worst prognosis is for IUGR caused by
congenital infection, congenital abnormalities
and chromosomal defects.
25. Mortality
• The immediate neonatal mortality is about 6
times more than the normal newborn or even
similar weight appropriate to the shorter
gestational age.
• Most of the babies die within 24 hours.
• The morbidity rate rises to about 50%.
26. Management during pregnancy
1. Adequate bed rest specially in left lateral position
(2 hours following lunch and 8 hours at night).
2. To correct malnutrition by adequately balanced
diet, 300 extra calories per day are to be taken.
3. Maternal hyper oxygenation 2.5 l/mt
4. Avoidance of smoking and alcohol.
5. Low dose aspirin (50 mg daily) for hypertention,
pre eclampsia may be helpful.
6. Detect fetal anomalies.
27. At delivery:
- IUGR infants are more prone to
hypoxemia during labor and delivery
because of uteroplacental insufficiency,
and more prone to cord compression due
to lack of amniotic fluid and a thin cord.
28. - A neonatal team capable of managing
asphyxia and meconium aspiration
syndrome should be available at the time
of delivery.
- Special attention should be addressed to
prevention of hypothermia and
hypoglycemia.
29. Management after birth:
1. Respiratory care – esp. with meconium
2. Hypoglycaemia due to low sugar
reserves and higher energy consumption – esp.
with cold stress.
30. 3. Hypothermia due to lack of
subcutaneous fat
4. infection – at risk as immature immune
system of babies is common
31. 5. Polycythaemia – due to in-utero hypoxia.
Can cause venous thrombo-emboli and
can also worsen cerebral ischaemia and
perpetuate hypoglycaemia.
6. Haemorrhage – can develop due to lack
of liver coagulation factor production, and
also may have low platelets if TORCH
7. Management of asphyxia
32. Investigations of SGA baby:
Initially, babies need to be examined in a
warm environment.
True blood glucose should be assessed at ½
to 1 hour of age, and pre-feeds for at least
the next 2 feeds. Feeds should be frequent
(2-3 hourly initially).
33. If baby jittery, then glucose and calcium
and magnesium must be checked.
Full blood count -
- polycythaemia
- platelet count
- white cells
34. Other investigations
- chromosomes
- TORCH screen
- CXR if respiratory distress
- Sepsis workup if possibility of infection -
- Urine drug screen, etc., if suspect
maternal substance abuse
35. Nutrition:
- Important to establish nutrition as early as
possible
- If delay in establishing enteral feeds, must
use TPN.
- Weight gain monitoring needed to ensure
sufficiency of caloric intake.
36. - It is common that caloric intake in IUGR
infants will exceed the usual intake of 100-
120 Kcal/kg/day, and daily weight gain will
exceed 25 g/day.
- Neurologic prognosis may relate directly to
restoring good nutrition